晚就诊STEMI患者经皮心肌血运重建的疗效分析
该研究基于法国FAST-MI三项全国性观察性队列(2005、2010、2015年),分析症状发作后12至48小时就诊的晚就诊STEMI患者。在1077例纳入分析的患者中,67.7%在入院48小时内接受血运重建;血运重建组30天全因死亡率显著低于未血运重建组(2.1% vs 7.2%,P<0.001),中位随访58个月期间全因死亡率为30.4 vs 78.7/1000人年(P<0.001),多因素分析显示血运重建与随访期间死亡率显著降低独立相关(HR 0.65,95%CI 0.50-0.84,P=0.001)。
要点
- 晚就诊STEMI患者接受血运重建与更低的30天全因死亡率相关(2.1% vs 7.2%)。
- 长期随访中血运重建组全因死亡率显著低于未血运重建组(30.4 vs 78.7/1000人年)。
- 血运重建与随访期死亡率降低独立相关(HR 0.65,95%CI 0.50-0.84)。
核心结论
- 晚就诊STEMI患者接受冠状动脉血运重建与更好的短期和长期临床结局相关。
研究设计与样本
- 基于法国FAST-MI项目三项全国性观察性研究(2005、2010、2015年各1个月)的分析。
- 共纳入6273例STEMI患者,其中1169例(18.6%)为晚就诊者(症状发作后12至48小时就诊)。
- 排除接受纤溶治疗及入院2天内死亡者后,1077例纳入分析,其中729例(67.7%)在入院48小时内接受血运重建。
主要发现
- 血运重建组30天全因死亡率显著低于未血运重建组(2.1% vs 7.2%,P<0.001)。
- 中位随访58个月,血运重建组全因死亡率为30.4(95%CI 25.7-35.9)/1000人年,未血运重建组为78.7(95%CI 67.2-92.3)/1000人年(P<0.001)。
- 多因素分析显示血运重建与随访期间死亡率显著降低独立相关(HR 0.65,95%CI 0.50-0.84,P=0.001)。
临床怎么用
- 对于症状发作后12至48小时就诊的STEMI患者,应考虑行冠状动脉血运重建以改善短期和长期预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal management of patients with ST-segment elevation myocardial infarction (STEMI) presenting late->12 hours following symptom onset-is still under debate. OBJECTIVES: The purpose of this study was to describe characteristics, temporal trends, and impact of revascularization in a large population of latecomer STEMI patients. METHODS: The authors analyzed the data of 3 nationwide observational studies from the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) program, conducted over a 1-month period in 2005, 2010, and 2015. Patients presenting between 12 and 48 hours after symptom onset were classified as latecomers. RESULTS: A total of 6,273 STEMI patients were included in the 3 cohorts, 1,169 (18.6%) of whom were latecomers. After exclusion of patients treated with fibrinolysis and patients deceased within 2 days after admission, 1,077 patients were analyzed, of whom 729 (67.7%) were revascularized within 48 hours after hospital admission. At 30-day follow-up, all-cause death rate was significantly lower among revascularized latecomers (2.1% vs 7.2%; P < 0.001). After a median follow-up of 58 months, the rate of all-cause death was 30.4 (95% CI: 25.7-35.9) per 1,000 patient-years in the revascularized latecomers group vs 78.7 (95% CI: 67.2-92.3) per 1,000 patient-years in the nonrevascularized latecomers group (P < 0.001). In multivariate analysis, revascularization of latecomer STEMI patients was independently associated with a significant reduction of mortality occurrence during follow-up (HR: 0.65 [95% CI: 0.50-0.84]; P = 0.001). CONCLUSIONS: Coronary revascularization of latecomer STEMI patients is associated with better short and long-term clinical outcomes.
引用
- Bouisset F, Gerbaud E, Bataille V, et al. Percutaneous Myocardial Revascularization in Late-Presenting Patients With STEMI. J Am Coll Cardiol. 2021. PMID: 34556314. doi:10.1016/j.jacc.2021.07.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。